Education
About Us
Working with TipRanks
Follow Us
Keith E Muckenhirn Insider Profile
4 Followers
Keith E Muckenhirn, VP/Controller & Interim CFO at Antares Pharma, holds 50.00K shares in Antares Pharma (Ticker: ATRS).
Keith E Muckenhirn Antares Pharma (ATRS)VP/Controller & Interim CFO
Antares Pharma (ATRS)
VP/Controller & Interim CFO
Not Ranked
Keith E Muckenhirn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Keith E Muckenhirn does not currently own shares as a corporate insider.
A breakdown of Keith E Muckenhirn's holdings
Insider Roles
Keith E Muckenhirn does not currently hold a role as a corporate insider.
Roles that Keith E Muckenhirn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Keith E Muckenhirn
Keith E Muckenhirn's Trading History
List of latest transactions for each holding click on a transaction to see Keith E Muckenhirn's performance on stock
You May Also Like
Keith E Muckenhirn insider profile FAQ
What is the percentage of profitable transactions made by Keith E Muckenhirn?
The percentage of profitable transactions made by Keith E Muckenhirn is ―.
What is the average return per transaction made by Keith E Muckenhirn?
The average return per transaction made by Keith E Muckenhirn is ―.
What stocks does Keith E Muckenhirn hold?
Keith E Muckenhirn holds: ATRS stocks.
What was Keith E Muckenhirn’s latest transaction?
Keith E Muckenhirn latest transaction was an Uninformative Buy of ―.
What was Keith E Muckenhirn's most profitable transaction?
Keith E Muckenhirn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Keith E Muckenhirn's role in Antares Pharma?
Keith E Muckenhirn's role in Antares Pharma is VP/Controller & Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.